<DOC>
	<DOCNO>NCT01110434</DOCNO>
	<brief_summary>Cannabis use significant public health concern disproportionately affect youth . Although promising psychosocial intervention develop , youth benefit intervention alone . Given clinical demand effective treatment , National Institute Drug Abuse ( NIDA ) identify critical need data tolerability potential efficacy medication adolescent . The purpose two-year study test topiramate , medication intense study treat several drug abuse , reduces cannabis use among teenager . To end , investigator randomize 56 nontreatment-seeking regular cannabis user ( 15 20 year old ) receive topiramate placebo 6 week . Youth monitor cannabis use 6-week period use handheld electronic diary complete assessment reactivity cannabis-related cue .</brief_summary>
	<brief_title>Biobehavioral Effects Topiramate Cannabis-Related Outcomes Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>15 20 year old ( inclusive ) Nontreatment seek cannabis abuse dependence Able read English , understand right provide informed consent process , willing sign inform consent form participant study If young 18 year old , informed consent parent legal guardian require Used cannabis least 2 day per week past 30 day Treatment seek recent history treatment cannabis abuse dependence Endorses current commitment stop use cannabis Clinically significant physical abnormality indicate physical exam , hematological assessment , bilirubin concentration urinalysis History renal impairment , renal stone , seizure , unstable hypertension Underweight ( i.e. , less 5th percentile ) overweight ( equal great 95th percentile ) , determine Body Mass Index Positive urine toxicology screen narcotic , amphetamine , sedative hypnotic selfreported drug use , cannabis , alcohol nicotine , past 30 day Pregnant , nursing , refusal use reliable barrier method birth control ( e.g. , condom ) , female Took psychotropic medication past 30 day Taking medication potential effect cannabis use carbonic anhydrase inhibitor Suicidal A current DSMIVTR Axis I diagnosis attention deficit/hyperactivity disorder disruptive behavior disorder A current substance use disorder cannabis , alcohol , nicotine use disorder Significant alcohol withdrawal symptom Known sensitivity topiramate</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>